• 综述与评论 •
叶霁青, 岳晓虹, 孙丽萍. 小分子IL-6/STAT3信号通路抑制剂[J]. 化学进展, 2016, 28(7): 1099-1111.
Ye Jiqing, Yue Xiaohong, Sun Liping. Small Molecule Inhibitors of IL-6/STAT3 Signaling[J]. Progress in Chemistry, 2016, 28(7): 1099-1111.
中图分类号:
分享此文:
[1] 侯嘉杰(Hou J J),孙倍成(Sun B C). 生物化学与生物物理进展(Progress in Biochemistry and Biophysics), 2014, 41:69. [2] Waldner M J, Sebastian F, Neurath M F. International Journal of Biological Sciences, 2012, 8:1248. [3] Kastritis E, Charidimou A, Varkaris A, Dimopoulos M A. Targeted Oncology, 2009, 4:23. [4] Hodge D R, Hurt E M, Farrar W L. European Journal of Cancer, 2005, 41:2502. [5] Miklossy G, Hilliard T S, Turkson J. Nature Reviews Drug Discovery, 2013, 12:611. [6] Akira S, Nishio Y, Inoue M, Wang X J, We S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. Cell, 1994, 77:63. [7] Camporeale A, Poli V. Frontiers in Bioscience, 2012, 17:2306. [8] Ren Z Y, Mao X, Mertens C, Krishnaraj R, Qin J, Mandal P K, Romanowski M J, McMurray J S, Chen X. Biochemical and Biophysical Research Communications, 2008, 374:1 [9] Lim C P, Cao X M. Molecular BioSystems, 2006, 2:536. [10] Li C, Cao X. Mol. BioSyst., 2006, 2:536. [11] Parka I H, Li C. J. Mol. Recognit., 2011, 24:254. [12] Johnston P A, Grandis J R. Mol. Interv., 2011, 11:18. [13] Aaronson D S, Horvath C M. Science, 2002, 296:1653. [14] Heinrich P C, Iris B, Serge H, Hermanns, H M, Gerhard M N, Fred S. Biochemical Journal, 2003, 374:1. [15] Krebs D L, Hilton D J. Journal of Cell Science, 2000, 113:2813. [16] Shuai K. Oncogene, 2000, 21:2638. [17] Shuai K, Liu B. Nat. Rev. Immunol., 2005, 5:593. [18] Yasukawa H, Sasaki A, Yoshimura A. Annu. Rev. Immunol., 2000, 18:143. [19] Yamada S, Shiono S, Joo A, Yoshimura A. FEBS Lett., 2003, 534:190. [20] Yu H, Kortylewski M, Pardoll D. Nat. Rev Immunol., 2007, 7:41. [21] Barbieri I, Pensa S, Pannellini T, Quaglino E, Maritano D, Demaria M, Voster A, Turkson J, Cavallo F, Watson C J, Provero P, Musiani P, Poli V. Cancer Res., 2010, 70:2558. [22] Wang L, Yi T M. Journal of Experimental Medicine, 2009, 206:1431. [23] 贾林梓(Jia L Z),冯英明(Feng Y M). 现代肿瘤医学(Journal of Modern Oncology), 2008, 16:2213. [24] Grivennikov S, Karin E, Terzic J, Mucida D, Yu G Y, Vallabhapurapu S, Scheller J, Stefan R J, Cheroutre H, Eckmann L, Karin M. Cancer Cell, 2009, 15:241. [25] Zheng T S, Hong X H, Wang J B, Pei T M, Liang Y J, Yin D L, Song R P, Song X, Lu, Shuyi Qi Z Y, Liu J R, Sun B S, Xie C M, Pan S G, Li Y J, Luo X H, Li S, Fang X, Bhatta N, Jiang H C, Liu L X. Hepatology, 2014, 59:935. [26] He M, Young C Y. Mini-Reviews in Medicinal Chemistry, 2009, 9:395. [27] Camporeale A, Poli V. Frontiers in Bioscience, 2012, 17:2306. [28] Debnath B, Xu S, Neamati S. J. Med. Chem., 2012, 55:6645. [29] Hayashi M, Rho M C, Enomoto A, Fukami A, Kim Y P, Kikuchi Y J, Sunazuka T, Hirose T, Komiyama K, Omura S. Proc. Natl. Acad. Sci. U. S. A., 2002, 99:14728. [30] Tyner J W, Bumm T G, Deininger J, Wood L, Aichberger K J, Loriaux M M, Druker B J, Burns C B, Fantino E, Deininger M W. Blood, 2010, 115:5232. [31] Hedvat M, Huszar D, Herrmann A, Herrmann H, Gozgit J M, Schroeder A, Sheehy A, Buettner R, Proia D, Kowolik C M, Xin H, Armstrong B, Bebernitz G, Weng S B, Wang L, Ye M W, McEachern K, Chen H W, Morosini D, Bell K, Alimzhanov M, Ioannidis S, McCoon P, Cao Z A, Yu H, Jove R, Zinda M. Cancer Cell, 2009, 16:487. [32] Hao Y S, Chapuy B, Monti S, Sun H, Rodig S J, Shipp M A. Blood, 2013, 122:4230. [33] Huang S B, Sinicrope F A. Molecular Cancer Thrapeutics, 2010, 9:742. [34] Ferrajoli A, Faderl S, Van Q, Van Q, Koch P, Harris D, Liu Z M, Halevy I H, Wang Y T, Kantarjian H M, Priebe W, Estrov Z. Cancer Research, 2007, 67:11291. [35] Bharti A C, Donato N, Aggarwal B B. Journal of Immunology, 2003, 171:3863. [36] Ren X M, Duan L, He Q, Zhang Z, Zhou Y, Wu D H, Pan J X, Pei D Q, Ding K. ACS Med. Chem. Lett., 2010, 1:454. [37] Song H, Wang R, Wang S, Lin J. Proc. Natl. Acad. Sci. U.S.A., 2005, 102:4700. [38] Siddiquee K, Zhang S, Guida W C, Blaskovich M A, Greedy B, Lawrence H R, Yip M L, Jove R, McLaughlin M M, Lawrence N J, Sebti S M, Turkson J. Proc. Natl. Acad. Sci. U.S.A., 2007, 104:7391. [39] Matsuno K J, Masuda Y, Uehara Y, Sato H, Muroya A, Takahashi O, Yokotagawa T, Furuya T, Okawara T, Otsuka M, Ogo N, Ashizawa T, Oshita C, Tai S, Ishii H, Akiyama Y, Asai A. Med. Chem. Lett., 2010, 1:371. [40] Schust J, Sperl B, Hollis A, Mayer T U, Berg T. Chemistry & biology, 2006, 13:1235. [41] Yu Z Y, Huang R, Xiao H, Sun W F, Shan Y J, Wang B, Zhao T T, Dong B, Zhao Z H, Liu X L, Wang S Q, Yang R F, Luo Q L, Cong Y W. International Journal of Cancer, 2010, 127:1259. [42] Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A. Prostate, 2008, 68:269. [43] Don-Doncow N, Escobar Z, Johansson M, Kjellström S, Garcia V, Munoz E, Sterner O, Bjartell A, Hellsten R. Journal of Biological Chemistry, 2014, 289:15969. [44] Bhasin D, Cisek K, Pandharkar T, Regan N, Li C L, Pandit B, Linb J Li P K. Bioorganic & Medicinal Chemistry Letters, 2008, 18:391. [45] Lin L, Hutzen B, Li P K, Ball S, Zuo M X, Angelis D S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C L, Lin J Y. Neoplasia, 2010, 12:39. [46] Yu W Y, Xiao H, Lin J, Li C L. J. Med. Chem., 2013, 56:4402. [47] Shi Z B, Zhang L, Bin Z Y, Cao X R, Gong Z N, Li J X. Letters in Drug Design & Discovery, 2013, 10:420. [48] Chen H J, Yang Z D, Ding C Y, Chu L L, Zhang Y S, Terry K, Liu H L, Shen Q, Zhou J. European Journal of Medicinal Chemistry, 2013, 62:498. [49] Chen H J, Yang Z D, Ding C Y, Chu L L, Zhang Y S, Terry K, Liu H L, Shen Q, Zhou J. ACS Med. Chem. Lett., 2013, 4:180. [50] Chen H J, Yang Z D, Ding C Y, Xiong A L, Wild C, Wang L L, Ye N, Cai G, Flores M R, Ding Y, Shen Q, Zhou J. European Journal of Medicinal Chemistry, 2014, 82:195. [51] Fletcher S, Singh J, Zhang X L, Yue P B, Page B D G, Sharmeen S, Shahani V M, Zhao W, Schimmer A D, Turkson J, Gunning P T. ChemBioChem, 2009, 10:1959. [52] Zhang X L, Yue P, Page B D G, Li T, Zhao W, Namanja A T, Paladino D, Zhao J H, Chen Y, Gunning P T, Turkson J. Proc. Natl. Acad. Sci. U. S. A., 2012, 109:9623. [53] Page B D G, Croucher D C, Li Z H, Haftchenary S, Jimenez-Zepeda V H, Atkinson J, Spagnuolo P A, Wong Y L, Colaguori R, Lewis A M, Schimmer A D, Trudel S, Gunning P T. J. Med. Chem., 2013, 56:7190. [54] Haftchenary S, Luchman H A, Jouk A O, Veloso A J, Page B D G, Cheng X R, Dawson S S, Grinshtein N, Shahani V M, Kerman K, Kaplan D R, Griffin C, Aman A M, Al-awar R, Weiss S, Gunning P T. ACS Med. Chem. Lett., 2013, 4:1102. [55] Urlam M K, Pireddu R, Ge Y Y, Zhang X L, Sun Y, Lawrence H R, Guida W C, Sebti S M, Lawrence N J. Med. Chem. Comm., 2013, 4:932. [56] Zhang X L, Sun Y, Pireddu R, Yang H, Urlam M K, Lawrence H R, Guida W C, Lawrence N J, Sebti S M. Cancer Res., 2013, 73:1922. [57] Zhang M M, Zhu W L, Li Y X. European Journal of Medicinal Chemistry, 2013, 62:301. [58] Ameriks M K, Bembenek S D, Burdett M T, Choong I C, Edwards J P, Gebauer D, Gu Y, Karlsson L, Purkey H E, Staker B L, Sun S Q, Thurmond R L, Zhu J. Bioorganic & Medicinal Chemistry Letters, 2010, 20:4060. [59] Revanna C. N, Basappa, Srinivasa V, Li F, Siveen K S, Dai X Y, Swamy S N, Bhadregowda D. G, Sethi G, Mantelingu K, Bender A, Rangappa K S. Med. Chem. Commun., 2014, 5:32. [60] Subash S, Subramanian P. Molecular and Cellular Biochemistry, 2009, 327:153. [61] Gupta S C, Phromnoi K, Aggarwal B B. Biochemical Pharmacology, 2013, 85:898. [62] Suematsu N, Hosoda M, Fujimori K. Neuroscience Letters, 2011, 504:223. [63] Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R. Experimental Cell Research, 2012, 318:925. [64] Cao H H, Tse A K, Kwan H, Yu H, Cheng C, Su T, Fong W F, Yu Z. Biochemical Pharmacology, 2014, 87:424. [65] Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M. Cancer Res., 2006, 66:4826. [66] Tan J, Luo D. US2011201565-A1, 2011. [67] Yang M Y, Wang C J, Chen N F, Ho W H, Lu F J, Tseng T H. Chemico-Biological Interactions, 2014, 213:60. [68] Lee J, Chiang S Y, Nama D, Chung W S, Lee J, Na Y S, Sethi G, Ahn K S. Cancer Letters, 2014, 345:140. [69] Li S S, Priceman S J, Xin H, Zhang W, Deng J H, Liu Y, Huang J B, Zhu W S, Chen M, Hu W, Deng X M, Zhang J, Yu H, He G Y. PloS One, 2013,8:e81657. [70] Zhu J F, Li Z J, Zhang G S, Meng K, Kuang W Y, Li J, Zhou X F, Rui juan Li, Peng H L, Dai C W, Shen J K, Gong F J, Xu Y X, Liu S F. PloS One., 2011, 6:e23720. [71] Xu H T, Zhang S Y. Phytother Research, 2013, 27:1524. [72] Zhao Y, Yao J, Wu X P, Zhao L, Zhou Y X, Zhang Y, You Q D, Guo Q L, Lu N, Molecular Carcinogenesis, 2014, 54:e81. [73] Xue P P, Zhao Y, Liu Y, Yuan Q Y, Xiong C M, Ruan J L. Chemico-Biological Interactions, 2014, 209:25. [74] Kim K J, Kim J Y, Kim H J, Park K G, Harris R A, Cho W J, Lee J T, Lee I K. PloS One, 2013, 8:65. [75] Kim S M, Lee J H, Sethi G, Kim C, Baek H S, Nam D, Chung W S, Kim S H, Shim B S, Ahn K S. Cancer Letters, 2014, 354:153. [76] Turkson J, Zhang S, Mora L B, Burns A, Sebti S, Jove R. J. Biol. Chem., 2005, 38:32979. [77] Turkson J, Zhang S, Palmer J, Kay H, Stanko J, Mora L B, Sebti S, Yu H, Jove R. Mol. Cancer Ther., 2004, 12:1533. [78] Kim N H, Lee M Y, Park S J, Choi J S, Oh M K, Kim I S. Immunology, 2007, 122:607. [79] Kim N H, Park H J, Oh M K, Kim I S. BMB Reports, 2013, 46:59. [80] Sebti S M, Lawrence N J, Turkson J. US20140303134 A1, 2013. [81] Ma D L, Liu L J, Leung K H, Chen Y T, Zhong H J, Chan D S H, Wang H M D, Leung C H. Angew. Chem., 2014, 126:1. [82] Huang W, Dong Z, Wang F, Peng H, Liu J Y, Zhang J T. ACS Chemical Biology, 2014, 9(5):1188. [83] Zhang M M, Zhu W L, Ding N, Zhang W, Li Y G. J. Bioorganic & Medicinal Chemistry Letters, 2013, 23:2225. [84] Bharadwaj U, Eckols T K, Kolosov M, Kasembeli M M., Adam A, Torres D, Zhang X, Dobrolecki L E, Wei W, Lewis M T, Dave B, Chang J C, Landis M D, Creighton C J, Mancini M A, Tweardy D J. Oncogene, 2014, 34:1. [85] Liu J W, Zhang Q, Ye Y S, Li W G, Liu J L, Zhan R T, Chen W W, Yu Q. Phytomedicine International Journal of Phytotherapy & Phytopharmacology, 2014, 21:1088. [86] Shanmugam M K, Rajendran P, Li F, Kim C, Sikka S, Siveen K S, Kumar A P, Ahn K S, Sethi G. Molecular Carcinogenesis, 2015, 54:971. [87] Xu S, Grande F, Garofalo A, Neamati N. Molecular Cancer Research, 2013, 12:937. [88] 岳晓虹(Yue X H),叶霁青(Ye J Q),孙丽萍(Sun L P).长三角药物化学研讨会会议论文集(Proceedings of Yangtze River Delta Symposium on Medicinal Chemistry),2014, 105. [89] 叶霁青(Ye J Q),岳晓虹(Yue X H),张海琪(Zhang H Q),李明涛(Li M T),孙丽萍(Sun L P). 长三角药物化学研讨会论文集(Proceedings of Yangtze River Delta Symposium on Medicinal Chemistry),2015. 41. [90] 赵璐(Zhao L). 中外医学研究(Chineses and Foreign Medical Research), 2012, 10:144. |
[1] | 顾顺心, 姜琴, 施鹏飞. 发光铱(Ⅲ)配合物抗肿瘤活性研究及应用[J]. 化学进展, 2022, 34(9): 1957-1971. |
[2] | 王欣瑜, 赵富平, 张儒, 孙子茹, 刘胜男, 高清志. 抗肿瘤缺氧诱导因子-1的小分子抑制剂[J]. 化学进展, 2021, 33(12): 2259-2269. |
[3] | 孙子茹, 刘胜男, 高清志. 靶向葡萄糖转运蛋白(GLUTs)抗癌药物的开发[J]. 化学进展, 2020, 32(12): 1869-1878. |
[4] | 徐子悦, 张运昌, 林佳乐, 王辉, 张丹维, 黎占亭. 药物输送体系构筑中的超分子组装策略[J]. 化学进展, 2019, 31(11): 1540-1549. |
[5] | 谭晓晓, 李国帅, 王庆鹏, 王炳全, 李大成, 王鹏. 作为抗肿瘤药物的小分子四价铂[J]. 化学进展, 2018, 30(6): 831-846. |
[6] | 李享, 石家愿, 邱爽, 王明芳, 刘长林*. SOD1抑制与活性氧信号转导的调控[J]. 化学进展, 2018, 30(10): 1475-1486. |
[7] | 何良, 谭彩萍, 曹乾, 毛宗万. 磷光环金属化铱(Ⅲ)配合物在癌症治疗方面的应用[J]. 化学进展, 2018, 30(10): 1548-1556. |
[8] | 孙悦文, 金素星, 王晓勇, 郭子建. 金属配合物在肿瘤化学免疫治疗中的应用前景[J]. 化学进展, 2018, 30(10): 1573-1583. |
[9] | 郑小辉, 夏立新, 毛宗万. 基于核酸修饰新策略的抗肿瘤铂配合物设计[J]. 化学进展, 2016, 28(7): 1029-1038. |
[10] | 李思迪, 侯信, 亓洪昭, 赵瑾, 原续波. 外泌体:为高效药物投递策略提供天然的内源性纳米载体[J]. 化学进展, 2016, 28(2/3): 353-362. |
[11] | 郭键, 贺耘, 叶新山. 唾液酸转移酶抑制剂的设计与发现[J]. 化学进展, 2016, 28(11): 1712-1720. |
[12] | 王家敏, 史蕾, 刘海洋. 咔咯及其金属配合物与DNA的作用和抗肿瘤活性[J]. 化学进展, 2015, 27(6): 755-762. |
[13] | 李晓晖*, 黄美玲, 刘丽娜, 王燕云. 环肽类组蛋白去乙酰化酶抑制剂[J]. 化学进展, 2014, 26(09): 1527-1536. |
[14] | 黎燕, 黄卫, 黄平, 朱新远, 颜德岳. 抗肿瘤药物输送系统[J]. 化学进展, 2014, 26(08): 1395-1408. |
[15] | 杨冬梅, 周宇涵, 常晴, 赵一龙, 曲景平. 三氟甲基烷基酮的生物活性及合成方法[J]. 化学进展, 2014, 26(06): 976-986. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||